China Institute Teams With Achillion Of U.S. To Make Hep B/HIV Drug
This article was originally published in PharmAsia News
Executive Summary
China's Tianjing Institute of Pharmaceutical Research has entered into a partnership with U.S. drug maker Achillion Pharmaceuticals to develop elvucitabine